Changes in urinary glucose concentration and body weight in patients treated with the selective SGLT2 inhibitor luseogliflozin
- Resource Type
- Article
- Source
- In
Diabetes Research and Clinical Practice December 2021 182 - Subject
- Language
- ISSN
- 0168-8227